Nanoparticle Strategy Shows Promise for Ectopic Pregnancy Diagnosis and Treatment
In mice, magnetic nanoparticles were able to target tissue associated with pregnancy, suggesting a possible way to locate and treat ectopic pregnancies. Ectopic implantation usually occurs in the fallopian tubes and can cause life-threatening bleeding, while standard ultrasound diagnosis and methotrexate treatment have notable failure rates. The experimental system was developed by researchers at Oregon State University and Oregon Health & Science University.
Ectopic pregnancy happens when a fertilized egg implants outside the uterine lining, with roughly 98% of cases in the fallopian tubes. These pregnancies cannot proceed normally and are a leading cause of first-trimester maternal death. In the U.S., they represent about 2% of pregnancies, around 100,000 annually, with roughly 30 deaths per year over the past six years.
The experimental approach uses cobalt-doped iron oxide nanoparticles given intravenously. In pregnant mice, they gathered in the placenta, enabling MRI detection. If the placenta is misplaced, an alternating magnetic field could heat the particles to disrupt placental function without surgery; they do not cross the placental barrier.
If validated in humans, this nanoparticle strategy could give clinicians another way to identify ectopic pregnancies earlier and may offer a nonsurgical treatment option. People facing ectopic pregnancy, especially those wanting to preserve fertility, could benefit from more accurate diagnosis and fewer invasive procedures. It may also reduce reliance on methotrexate, whose side effects and failure rates complicate care. Still, human safety, effectiveness, and long-term reproductive outcomes remain uncertain.